Rebecka Borjesson-Papaioannu

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Highlighting advances on clinical management of pediatric HIV.

Highlighting advances on clinical management of pediatric HIV.

Journal: Expert opinion on pharmacotherapy

Published: February 25, 2026

Effectiveness of switching regimen in people living with HIV and persistent low-level viraemia in the modern antiretroviral treatment era.

Effectiveness of switching regimen in people living with HIV and persistent low-level viraemia in the modern antiretroviral treatment era.

Journal: HIV medicine

Published: October 22, 2025

Epidemiology, Pathogenesis, Clinical Features, and Management of Non-HACEK Gram-Negative Infective Endocarditis.

Epidemiology, Pathogenesis, Clinical Features, and Management of Non-HACEK Gram-Negative Infective Endocarditis.

Journal: Antibiotics (Basel, Switzerland)

Published: August 27, 2025

Addressing late HIV presentation: the current knowledge and unmet needs.

Addressing late HIV presentation: the current knowledge and unmet needs.

Journal: Expert review of anti-infective therapy

Published: July 07, 2025

Anti-cluster A and anti-p24 antibodies in people with multidrug-resistant HIV: Preliminary observations from the PRESTIGIO registry.

Anti-cluster A and anti-p24 antibodies in people with multidrug-resistant HIV: Preliminary observations from the PRESTIGIO registry.

Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

Published: June 15, 2025

Durability of multi-drug antiretroviral therapy (mega-ART) in treatment-experienced people with HIV in the ARCA database.

Durability of multi-drug antiretroviral therapy (mega-ART) in treatment-experienced people with HIV in the ARCA database.

Journal: Antiviral therapy

Published: April 14, 2025

Persistence of CXCR4-tropic virus in people living with four-class drug-resistant HIV and its clinical impact in the modern antiretroviral era.

Persistence of CXCR4-tropic virus in people living with four-class drug-resistant HIV and its clinical impact in the modern antiretroviral era.

Journal: The Journal of antimicrobial chemotherapy

Published: November 27, 2024

Sexually transmitted infections in MSM with tenofovir/emtricitabine-resistant or cabotegravir-resistant HIV.

Sexually transmitted infections in MSM with tenofovir/emtricitabine-resistant or cabotegravir-resistant HIV.

Journal: AIDS (London, England)

Published: November 23, 2024

PRESTIGIO RING: "A 28-year-old highly treatmentexperienced man with vertical HIV infection on ibalizumab therapy: ART simplification perspectives".

PRESTIGIO RING: "A 28-year-old highly treatmentexperienced man with vertical HIV infection on ibalizumab therapy: ART simplification perspectives".

Journal: The new microbiologica

Published: November 19, 2024

Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry.

Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry.

Journal: The Journal of antimicrobial chemotherapy

Published: September 02, 2024

Outcomes after a virological failure to first-line second-generation INSTI-based therapy in a real-life setting.

Outcomes after a virological failure to first-line second-generation INSTI-based therapy in a real-life setting.

Journal: The Journal of antimicrobial chemotherapy

Published: August 06, 2024

Long-term outcome in a person with pandrug-resistant HIV: the added value of a multidisciplinary approach.

Long-term outcome in a person with pandrug-resistant HIV: the added value of a multidisciplinary approach.

Journal: JAC-antimicrobial resistance

Published: May 17, 2024

Showing 1-12 of 16

Last Updated: 09/26/2026